Search research articles
Contact Us
Filters
Showing results (1-10 of 322) with videos related to
Page
of 33
Sort By:
Drug Development Research
|
November 11, 2014
Hyperuricemia in patients with chronic plaque psoriasis
Paolo Gisondi
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 25, 2026
Biologics and the psoriatic march: Is it time to rethink early intervention?
Paolo Gisondi
Seminars in Thrombosis and Hemostasis
|
May 20, 2009
Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors
Paolo Gisondi, Giampiero Girolomoni
Autoimmunity Reviews
|
September 15, 2007
Biologic therapies in psoriasis: a new therapeutic approach
Paolo Gisondi, Giampiero Girolomoni
Dermatology (Basel, Switzerland)
|
July 30, 2008
Psoriasis and metabolic comorbidities: the importance of well-designed prospective studies. Commentary
Giampiero Girolomoni, Paolo Gisondi
The Journal of Dermatological Treatment
|
October 30, 2016
Patients' perspectives in the management of psoriasis: the Italian results of the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey
Paolo Gisondi, Giampiero Girolomoni
Sexually Transmitted Diseases
|
March 21, 2022
Corymbose Syphilis
Paolo Gisondi, Francesco Bellinato
Expert Opinion on Biological Therapy
|
May 29, 2020
Brodalumab in the treatment of chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni
The Journal of International Medical Research
|
September 30, 2016
Glomerular filtration rate in patients with psoriasis treated with etanercept
Paolo Gisondi, Giampiero Girolomoni
Journal of Cutaneous Medicine and Surgery
|
May 16, 2022
Scurvy as Presenting Sign of Anorexia Nervosa
Paolo Gisondi, Francesco Bellinato
Page
of 33
Search research articles
Search
Showing results (1-10 of 322) with videos related to
Sort By:
Page
of 33
Drug Development Research
|
November 11, 2014
Hyperuricemia in patients with chronic plaque psoriasis
Paolo Gisondi
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 25, 2026
Biologics and the psoriatic march: Is it time to rethink early intervention?
Paolo Gisondi
Seminars in Thrombosis and Hemostasis
|
May 20, 2009
Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors
Paolo Gisondi, Giampiero Girolomoni
Autoimmunity Reviews
|
September 15, 2007
Biologic therapies in psoriasis: a new therapeutic approach
Paolo Gisondi, Giampiero Girolomoni
Dermatology (Basel, Switzerland)
|
July 30, 2008
Psoriasis and metabolic comorbidities: the importance of well-designed prospective studies. Commentary
Giampiero Girolomoni, Paolo Gisondi
The Journal of Dermatological Treatment
|
October 30, 2016
Patients' perspectives in the management of psoriasis: the Italian results of the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey
Paolo Gisondi, Giampiero Girolomoni
Sexually Transmitted Diseases
|
March 21, 2022
Corymbose Syphilis
Paolo Gisondi, Francesco Bellinato
Expert Opinion on Biological Therapy
|
May 29, 2020
Brodalumab in the treatment of chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni
The Journal of International Medical Research
|
September 30, 2016
Glomerular filtration rate in patients with psoriasis treated with etanercept
Paolo Gisondi, Giampiero Girolomoni
Journal of Cutaneous Medicine and Surgery
|
May 16, 2022
Scurvy as Presenting Sign of Anorexia Nervosa
Paolo Gisondi, Francesco Bellinato
Page
of 33